Evidence map›Paper›PMID 41917119›Full record

ArticleScientific reports2026

Morphology-guided deep learning for nanoparticle agglomeration diagnostic assays.

Kartik Jhawar, Xiao-Liu Chu, Joseph B DeGrandchamp, Yueming Yin, Lalitha Anjali Peddibhotla, Shabina Banu, Farah Najwa Nabila Mohd Hatta, Yaoli Wang, Peter Török, Lipo Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kartik Jhawar *Institute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Xiao-Liu Chu *Institute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Joseph B DeGrandchamp *Institute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Yueming YinInstitute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Lalitha Anjali PeddibhotlaInstitute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Shabina BanuInstitute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Farah Najwa Nabila Mohd HattaInstitute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore.
Yaoli WangCollege of Electronic and Information Engineering, Taiyuan University of Technology, Taiyuan, China.
Peter TörökInstitute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore. peter.torok@ntu.edu.sg.
Lipo WangInstitute for Digital Molecular Analytics and Science, Nanyang Technological University, Singapore, 636921, Singapore. elpwang@ntu.edu.sg.

Funding

Institute for Digital Molecular Analytics and Science, NTU EDUNC-33-18-279-V12
6 · The paper itself

Abstract

Accurate and rapid diagnostic tests that are simultaneously affordable remain elusive, typically due to trade-offs between performance and cost. Conventional nucleic acid tests offer high sensitivity but require complex, expensive steps such as amplification and purification, whereas lateral flow assays are simple and low-cost but lack the necessary sensitivity for many applications. New analytical approaches provide an opportunity to bridge this gap, raising sensitivity but not material expense. We present a miniaturized and simplified chip-based platform that combines three components into a single diagnostic pipeline: we use (i) spectrally distinct silver and gold nanoparticles (NPs) that form analyte-dependent clusters with unique spectral fingerprints, (ii) a one-pot, enzyme- and purification-free assay on a chip integrated with a high-throughput automated low-cost microscope, and (iii) a morphology-guided convolutional Graph Neural Network that embeds morphology information into convolutional kernels and performs graph-based relational learning across particle-level features. This integration captures spectral, spatial, and morphological quantification at the particle level, rather than relying on bulk spectral shifts, thereby addressing key limitations observed in representative nanoparticle (NP) assays and image-level deep learning baselines under particle-parallel analysis. Mc-GNN is able to process up to 5,000 particle crops per image in a single computational step, using less than 2 GB of GPU memory. This allows us to achieve femtomolar sensitivity with 98.2% recall for synthetic DNA and 94.8% for SARS-CoV-2 RNA from whole viruses, within in-domain experimental variability arising from different NP combinations and assay conditions. By embedding morphological information into the biosensing pipeline, our diagnostic platform is computationally efficient with millisecond-scale neural compute per raw image on a single consumer-grade GPU and is readily extensible to new analytes and multiplexing, offering a scalable solution for a fieldable diagnostic tool.

Indexed as

COVID-19Deep LearningMetal NanoparticlesConvolutional Neural NetworksGoldGraph Neural NetworksHumansRapid Diagnostic TestsSARS-CoV-2SilverGoldSilverDark-field microscopyFemtomolar sensitivityGraph neural networkMorphology-guided convolutionNP clusteringOptical barcodesSARS-CoV-2

Identifiers

PMID41917119
PMCPMC13180960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.